News
January 10, 2008 – Molecular imaging agents development will enhance the use of single photon emission computed tomography (SPECT) and positron emission tomography (PET) for early diagnosis of disease, according to the report Molecular Imaging Agents: Evolving Capabilities, Emerging Opportunities.
January 09, 2008
News
January 10, 2008 - Piedmont Hospital has been recognized as Best in Atlanta for Overall Cardiac Care and Cardiac Surgery ...
January 09, 2008News
January 10, 2008 - The Sudden Cardiac Arrest Association (SCAA), based in Washington, DC, launched its first 13 local ...
January 09, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
January 9, 2008 - Frost & Sullivan has recognized Philips Medical Systems with the 2007 North American Medical Imaging ...
January 08, 2008News
January 9, 2008 - The Certification Commission for Healthcare Information Technology with its software design partner ...
January 08, 2008News
January 9, 2008 - Avista Capital Partners, a leading private equity firm, has completed its acquisition of Bristol-Myers ...
January 08, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
January 7, 2008 - Ischemia experienced in brief episodes could protect the heart by preparing it for a heart attack, according to early findings from an animal study by researchers at the University of Cincinnati, which was published in the January issue of the American Journal of Physiology: Heart and Circulatory Physiology.
January 07, 2008News
January 8, 2007 - Cardiac Science Corp. expects 2007 fourth quarter revenue to total approximately $50 million, representing growth of approximately 28 percent compared with the fourth quarter of 2006, thanks to strong growth in revenue from its defibrillation products and cardiac monitoring line.
January 07, 2008News
January 8, 2008 - Compared with paclitaxel-eluting stents (PES), sirolimus-eluting stents (SES) appear to decrease the risk of in-stent late luminal loss in diabetics with coronary artery disease, new research shows.
January 07, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
January 8, 2008 – The cardiac imaging community has until Jan. 12 to contribute to the Centers for Medicare and Medicaid ...
January 07, 2008News
January 8, 2008 - GE Healthcare has initiated a vendor-independent educational program, designed specifically for ...
January 07, 2008News
January 8, 2008 – Young, obese women with polycystic ovary syndrome (PCOS) may be at increased risk for early subclinical coronary atherosclerosis, independent of the presence of traditional cardiovascular risk factors and novel inflammatory risk markers, according to a study by researchers at the University of Iowa published in the December issue of the Journal of Clinical Endocrinology and Met
January 07, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
January 7, 2008 - Imaging for early cardiovascular disease that causes heart attack and stroke is the focus of the High ...
January 06, 2008News
January 7, 2008 - Boston Scientific Corp. has completed the sale of its Cardiac Surgery and Vascular Surgery businesses ...
January 06, 2008News
January 7, 2008 - Osiris Therapeutics Inc. has reclaimed sole worldwide rights to cardiovascular indications for Prochymal and terminated its development and commercialization agreement with Boston Scientific Corp. in order to provide Osiris with the flexibility to enter more strategically beneficial relationships.
January 06, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now